Christopher Gardner
Director, Research and Development at Quorum Innovations
Based in Gainesville, United States
7-day free trial · no credit card
Seniority
Director
Department
Research & Development
Location
Gainesville
Industry
Biotechnology Research
Company size
2
Contact information
Reveal Christopher's email and phone
Direct contact data is gated. Sign up and reveal. You only pay for verified records.
c•••••••@quoruminnovations.com
Phone
5 credits+1 ••• •••• ••••
You only pay for valid records. Bounced emails and disconnected numbers cost nothing.
Background
About Christopher Gardner
I am a Master Biological Scientist at the University of Florida with over 13 years of professional experience in clinical laboratories and research projects. During the execution of these projects, I established a firm grasp of a wide variety of techniques associated with microbiology, molecular biology, biochemistry, and genetics. My educational background is highlighted by a B.S. in Microbiology and Cell Science in 2010. Achieved title of Biological Scientist IV, the highest level for a Biological Scientist in research. Held role of Lead Scientists for a drug discovery project involving the usage of microbiology, biochemistry, and molecular biology techniques to identify chemicals to treat citrus greening disease – these efforts positioned the research group for approximately $4M in funding to examine the efficacy of the compounds in field trials. Designed a pneumatic trunk injection system that decreased treatment application times 90% and increased deliverable capacity 20-fold. Identified a new probiotic bacteria species (Lactobacillus johnsonii N6.2) characterized/identified as a mechanism that could be used to prevent onsets of type 1 diabetes; oversaw animal studies and 3 clinical trials to examine the efficacy of L. johnsonii in humans with type one diabetes. Acted as Lead Scientist for the production of artificial extracellular vesicles designed to deliver proteins and genetic materials from L. johnsonii to high-risk patients (premature/neonatal babies) without direct exposure to live bacteria. Contributed to 21 scientific publications in high impact journals, with an additional 5 publications pending review.
Decision-makers
Other people at Quorum Innovations
Build a list of verified contacts at Quorum Innovations
Free for 7 days · 50 credits · no card · only pay for verified records.
Reach more buyers like Christopher
250M+ professionals with verified email and phone. You only pay for records that actually verify.
7-day trial · no credit card · cancel anytime